KYLE L COLVIN

Allopathic & Osteopathic Physicians|Radiology|Diagnostic Radiology SPOKANE, WA NPI 1902808363

General Payments — all program years on this page

$18,734.45

  • Category: General Payments
  • Program years: PY2018–2020
  • Record count: 75
  • As of (CMS publication): 2026-01-23

Latest program year (PY2020): $1,632.05 across 9 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2020) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $1,025.003
Travel and Lodging $543.054
Food and Beverage $64.002

By paying entity

Latest program year (PY2020) · sorted by reported total.

Paying entityAmountRecords
Takeda Pharmaceuticals U.S.A., Inc. $1,632.059

By program year

Program yearAmountRecords
2018 $11,315.1445
2019 $5,787.2621
2020 $1,632.059

Records — PY2020 (9)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
747334783 Takeda Pharmaceuticals U.S.A., Inc. $325.00 01/22/2020 Consulting Fee Undisputed 01/23/2026 View at CMS
747334785 Takeda Pharmaceuticals U.S.A., Inc. $34.13 01/22/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
747334787 Takeda Pharmaceuticals U.S.A., Inc. $82.05 01/22/2020 Travel and Lodging Undisputed 01/23/2026 View at CMS
747334789 Takeda Pharmaceuticals U.S.A., Inc. $525.00 01/30/2020 Consulting Fee Undisputed 01/23/2026 View at CMS
747334791 Takeda Pharmaceuticals U.S.A., Inc. $29.87 01/30/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
747334793 Takeda Pharmaceuticals U.S.A., Inc. $29.48 01/30/2020 Travel and Lodging Undisputed 01/23/2026 View at CMS
747334795 Takeda Pharmaceuticals U.S.A., Inc. $421.81 01/30/2020 Travel and Lodging Undisputed 01/23/2026 View at CMS
747334797 Takeda Pharmaceuticals U.S.A., Inc. $175.00 08/20/2020 Consulting Fee Undisputed 01/23/2026 View at CMS
747334799 Takeda Pharmaceuticals U.S.A., Inc. $9.71 08/20/2020 Travel and Lodging Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.